Novo said Monday's move was part of a broader push to expand access to "authentic, FDA-approved semaglutide medicines." The Danish drugmaker has struggled this year to fend off competition from Lilly, which moved faster to offer its drug to cash payers, and from pharmacies and telehealth providers selling cheaper copies of Wegovy
At this time, GLP1 receptor agonists are not approved for Alzheimers disease
Accessibility Toolbar
Lin J, Huang Y, Xu B, Gu X, Huang J, Sun J, Jia L, He J, Huang C, Wei X, Chen J, Chen X, Zhou J, Wu L, Zhang P, Zhu Y, Xia H, Wen G, Liu Y, Liu S, Zeng Y, Zhou L, Jia H, He H, Xue Y, Wu F, Zhang H
Clinical trials show an average of 34 kg (approximately 45% of body weight) reduction when taking 14mg for 6 months to 1 year
While GLP-1 drugs have been used for years to manage type 2 diabetes, the newer versions of these drugs are now in the spotlight for a different reason: weight loss